News for Medifast, Inc. (MED)

All three major U.S. indices are red in Wednesday's midday trading as investors weighed President Donald Trump's proposed tariffs on auto imports, pharmaceuticals and semiconductors.

Revenue: $119 million for Q4 2024, a decrease of 37.7% year-over-year.Gross Profit: $88.2 million, down 37.6% year-over-year; Gross profit margin improved to 7

Feb 18, 2025 / 09:30PM GMTOperator Greetings, and welcome to the Medifast fourth-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, t

Discover how Medifast navigates GLP-1 market shifts with innovative products like OPTAVIA ASCEND, cost-saving initiatives, and growth strategies for 2025.

Medifast, Inc. (NYSE:MED) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ETCompany ParticipantsSteven Zenker - Vice President, Investor...

Medifast (MED) delivered earnings and revenue surprises of 137.04% and 7.70%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Revenue: $119.0 million, surpassing the estimated $114.25 million for the quarter.Earnings Per Share (EPS): $0.07, exceeding the estimated EPS of -$0.16.Net In

[url="]Medifast[/url] (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, [url="]OPTA[/url][url="]VIA®

The following slide deck was published by Medifast, Inc.

Read here for a detailed financial analysis of Medifast stock post-pandemic, GLP-1 impact, and the company's collaboration with LifeMD.

Medifast Inc. (MED) experienced a 5.26% drop in stock price, now trading at $19.09 with a trading volume of 88,265 shares and a turnover rate of 0.81%. The stoc

[url="]Medifast[/url] (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution [url="]OPTA[/url][url="]VIA®[

Shares of Medifast Inc (MED) surged 4.53% in mid-day trading on Nov 27. The stock reached an intraday high of $19.30, before settling at $19.15, up from its

Medifast Inc. (MED) experienced a notable stock decline with a 5.08% drop, trading at $18.87 per share. The trading volume was 81,106 shares, with a turnover ra

Medifast's strong quarterly performance, investments in growth strategies, and undervalued stock make it an attractive opportunity for investors. Read more here.

Medifast, Inc. (NYSE:MED) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ETCompany ParticipantsSteven Zenker - Vice President-Investor...

The following slide deck was published by Medifast, Inc.

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

Revenue: $168.6 million, a decrease of 43.1% year-over-year.Gross Profit: $123.4 million, a decrease of 41.4% year-over-year.Gross Profit Margin: Improved by 2